YU46001B - Postupak za dobijanje novih peptida - Google Patents
Postupak za dobijanje novih peptidaInfo
- Publication number
- YU46001B YU46001B YU34586A YU34586A YU46001B YU 46001 B YU46001 B YU 46001B YU 34586 A YU34586 A YU 34586A YU 34586 A YU34586 A YU 34586A YU 46001 B YU46001 B YU 46001B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- procedure
- obtaining new
- insulin
- new peptides
- charge
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
POSTUPAK ZA DOBIJANJE NOVIH PEPTIDA, opste formule I gde slova A i B sledstveno oznakama u zagradama, oznacavaju delove peptida iz A- i B-Lanca, odnosno, oznaceni oznakama u zagradama, radikali E1, E2, E3 i E4 su Glu ili Gln ili ostatak neutralne amino kiseline, koji moze biti kodiran pomocu nukleotidnih nizova, X predstavlja L-trionin, L-arginin ili L-Lizin ostatak, Y i Z su isti ili razliciti i svaki od njih predstavlja ostatak amino kiseline, gde bilo koja strana lanca moze biti alkilirana i gde bilo koja strana lanca hidroksi grupe, moze biti alkilirana, m je 0, a n je 0 ili 1, s tim sto m i n mogu imati jednake ili razlicite vrednosti, i R predstavlja amido ili ester ostatak kojim se blokira C-pozicija karboksilne grupe B-Lanca, uz uslov da nisu svi od E1, E2, E3 glutamik ostaci kiseline, kad je X ostatak triionina, ili kad je E1, E2, E3 ostatak glutamik kiseline, a X je ostatak triionina, ili kad je E1, E2, E3 ostatak glutamik kiseline, a X je ostatak triionina, grupa iz formule -Ym-Zn-R predstavlja -NH2,Arg-NH2,Arg-NH2,-Arg-Arg-NH2, Arg-Arg-Nh2,-Arg-Lys-NH2,-Dap-Dap-NH2,-Lys-(Lau)-NH2,-Lys,Arg-NH2, -Lys-Lys-NH2, -Orn-NH2 ili -Orn-Orn-NH2, s tim sto je katalizator tripsin ili enzim tipa tripsina, naznacen time sto se vrsi transpeptidacija svinjskog insulina ili jedinjenja opste formule II: B(1-12)-E3-B(14-20)-E4-B(22-26)-X-B(28-29)-(Qq-R)-A(1-3)-E1-A(5-16)-E2-A(18-21) gde A i B oznacavaju fragmente A- i B-lanca oznacenih brojevima u zagradama. Q je peptidni lanac sa q aminokiselinama, q predstavlja ceo broj od 0 do 33, R je Lys ili Arg, dok je r jednako nuli ili jedan a E1, E2, E3 i E4, svaki ponaosob predstavljaju ostatak glutamik kiseline, dok X predstavlja ostatak treonina, - sa jedinjenjem opste formule III H-Ym-Zn-R gde Y i Z su isti ili razliciti i svaki od njih predstavlja ostatak amino kiseline, gde bilo koja strana lanca moze biti alkilirana i gde bilo koja strana lanca hidroksi grupe, moze biti alkilirana, gde m i n nisu isti ili razliciti, i svaki od njih predstavlja nulu ili jedan; gde R predstavlja amido ili ester ostatak kojim se blokira C-pozicija karboksilne grupe B-lanca, i gde amino grupe i hidroksi grupe bocnog lanca u Y i Z su opciono blokirane amino i hidroksi zastitnim grupama, uz koriscenje tripsina ili enzima tipa tripsina kao katalizatora, odnosno jedinjenja prema formuli IV gde E1, E2, E3, E4 i X imaju svaki napred opredeljena znacenja, sa jedinjenjem prema formuli III putem tripsina ili enzima tipa tripsina. Prijava sadrzi jos 8 zavisnih zahteva i 1 nezavisni zahtev.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK113585A DK113585D0 (da) | 1985-03-12 | 1985-03-12 | Nye peptider |
Publications (2)
Publication Number | Publication Date |
---|---|
YU34586A YU34586A (en) | 1988-10-31 |
YU46001B true YU46001B (sh) | 1992-12-21 |
Family
ID=8101410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU34586A YU46001B (sh) | 1985-03-12 | 1986-03-10 | Postupak za dobijanje novih peptida |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0194864B1 (sh) |
JP (1) | JPS61212598A (sh) |
KR (1) | KR930007433B1 (sh) |
CN (1) | CN86101489A (sh) |
AT (1) | ATE77391T1 (sh) |
AU (1) | AU612964B2 (sh) |
CS (1) | CS259536B2 (sh) |
DD (1) | DD244345A5 (sh) |
DE (1) | DE3685668T2 (sh) |
DK (2) | DK113585D0 (sh) |
ES (1) | ES8800276A1 (sh) |
FI (1) | FI861007A (sh) |
GR (1) | GR860687B (sh) |
HU (1) | HU201097B (sh) |
IL (1) | IL78103A0 (sh) |
MY (1) | MY102102A (sh) |
NO (1) | NO172441C (sh) |
NZ (1) | NZ215445A (sh) |
PH (1) | PH24260A (sh) |
PT (1) | PT82173B (sh) |
YU (1) | YU46001B (sh) |
ZA (1) | ZA861432B (sh) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK347086D0 (da) * | 1986-07-21 | 1986-07-21 | Novo Industri As | Novel peptides |
US5008241A (en) * | 1985-03-12 | 1991-04-16 | Novo Nordisk A/S | Novel insulin peptides |
DK119785D0 (da) * | 1985-03-15 | 1985-03-15 | Nordisk Gentofte | Insulinpraeparat |
DK437786D0 (da) * | 1986-09-12 | 1986-09-12 | Nordisk Gentofte | Insulinprecursorer |
US5149777A (en) * | 1988-07-20 | 1992-09-22 | Novo Nordisk A/S | Human insulin analogs and preparations containing them |
DE3827533A1 (de) * | 1988-08-13 | 1990-02-15 | Hoechst Ag | Pharmazeutische zubereitung zur behandlung des diabetes mellitus |
DE3837825A1 (de) * | 1988-11-08 | 1990-05-10 | Hoechst Ag | Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
DK134189D0 (da) * | 1989-03-20 | 1989-03-20 | Nordisk Gentofte | Insulinforbindelser |
US5130298A (en) * | 1989-05-16 | 1992-07-14 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
DE3936876A1 (de) * | 1989-11-06 | 1991-05-23 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
US6933272B1 (en) | 1998-09-22 | 2005-08-23 | Erik Helmerhorst | Use of non-peptidyl compounds for the treatment of insulin related ailments |
AUPP609198A0 (en) * | 1998-09-22 | 1998-10-15 | Curtin University Of Technology | Use of non-peptidyl compounds for the treatment of insulin related ailments |
DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
DE10227232A1 (de) | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Saure Insulinzubereitungen mit verbesserter Stabilität |
CN103215328B (zh) | 2004-01-21 | 2016-08-03 | 诺和诺德医疗保健公司 | 转谷氨酰胺酶介导的肽的接合 |
ATE519780T1 (de) | 2005-12-28 | 2011-08-15 | Novo Nordisk As | Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen |
DE102006031955A1 (de) * | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende |
DE102006031962A1 (de) * | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Amidiertes Insulin Glargin |
ES2613152T3 (es) | 2008-01-09 | 2017-05-22 | Sanofi-Aventis Deutschland Gmbh | Nuevos derivados de insulina con perfil tiempo/acción extremadamente retardado |
DE102008003566A1 (de) * | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
EP2229406B1 (de) * | 2008-01-09 | 2015-04-22 | Sanofi-Aventis Deutschland GmbH | Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil |
KR101820024B1 (ko) | 2008-10-17 | 2018-01-18 | 사노피-아벤티스 도이칠란트 게엠베하 | 인슐린과 glp-1 효능제의 병용물 |
US20120241356A1 (en) * | 2009-07-06 | 2012-09-27 | Sanofi-Aventis Deutschland Gmbh | Heat- and vibration-stable insulin preparations |
LT2498801T (lt) | 2009-11-13 | 2018-05-10 | Sanofi-Aventis Deutschland Gmbh | Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną |
PL3417871T3 (pl) | 2009-11-13 | 2021-06-14 | Sanofi-Aventis Deutschland Gmbh | Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę |
WO2011141407A1 (en) * | 2010-05-10 | 2011-11-17 | Novo Nordisk A/S | Process for the preparation of insulin-zinc complexes |
MX339614B (es) | 2010-08-30 | 2016-06-02 | Sanofi - Aventis Deutschland GmbH | Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2. |
CN102174495A (zh) * | 2011-01-20 | 2011-09-07 | 马忠仁 | 一种提取糜胰蛋白酶的方法 |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
PL2750699T3 (pl) | 2011-08-29 | 2015-12-31 | Sanofi Aventis Deutschland | Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2 |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
CA2970200A1 (en) | 2014-12-12 | 2016-06-16 | Sanofi-Aventis Deutschland Gmbh | Insulin glargine/lixisenatide fixed ratio formulation |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK319780A (da) * | 1980-07-24 | 1982-01-25 | Forenede Bryggerier As | Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner |
DE3326472A1 (de) * | 1983-07-22 | 1985-02-14 | Hoechst Ag, 6230 Frankfurt | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
DE3333640A1 (de) * | 1983-09-17 | 1985-04-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung |
DK119785D0 (da) * | 1985-03-15 | 1985-03-15 | Nordisk Gentofte | Insulinpraeparat |
-
1985
- 1985-03-12 DK DK113585A patent/DK113585D0/da unknown
-
1986
- 1986-02-26 ZA ZA861432A patent/ZA861432B/xx unknown
- 1986-02-27 PH PH33459A patent/PH24260A/en unknown
- 1986-03-10 DK DK107086A patent/DK158677C/da active
- 1986-03-10 YU YU34586A patent/YU46001B/sh unknown
- 1986-03-10 DD DD86287734A patent/DD244345A5/de not_active IP Right Cessation
- 1986-03-11 KR KR1019860001737A patent/KR930007433B1/ko active IP Right Grant
- 1986-03-11 JP JP61051586A patent/JPS61212598A/ja active Pending
- 1986-03-11 CN CN198686101489A patent/CN86101489A/zh active Pending
- 1986-03-11 AT AT86301755T patent/ATE77391T1/de not_active IP Right Cessation
- 1986-03-11 ES ES552879A patent/ES8800276A1/es not_active Expired
- 1986-03-11 FI FI861007A patent/FI861007A/fi not_active Application Discontinuation
- 1986-03-11 CS CS861666A patent/CS259536B2/cs unknown
- 1986-03-11 AU AU54495/86A patent/AU612964B2/en not_active Ceased
- 1986-03-11 NO NO860920A patent/NO172441C/no unknown
- 1986-03-11 PT PT82173A patent/PT82173B/pt not_active IP Right Cessation
- 1986-03-11 IL IL78103A patent/IL78103A0/xx not_active IP Right Cessation
- 1986-03-11 NZ NZ215445A patent/NZ215445A/xx unknown
- 1986-03-11 DE DE8686301755T patent/DE3685668T2/de not_active Expired - Fee Related
- 1986-03-11 HU HU861024A patent/HU201097B/hu not_active IP Right Cessation
- 1986-03-11 EP EP86301755A patent/EP0194864B1/en not_active Expired - Lifetime
- 1986-03-12 GR GR860687A patent/GR860687B/el unknown
-
1987
- 1987-09-30 MY MYPI87002520A patent/MY102102A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU46001B (sh) | Postupak za dobijanje novih peptida | |
ES2061504T3 (es) | Nuevos peptidos. | |
ES2012720A6 (es) | Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada. | |
IT8647912A0 (it) | Procedimento enzimatico per preparare l'amminoacidi contenenti zolfo | |
DK376187A (da) | Peptider |